| Amura Therapeutics Limited Patent applications |
| Patent application number | Title | Published |
|---|
| 20110077254 | COMPOUNDS - A compound of formula (I), or a pharmaceutically acceptable salt, hydrate, complex or pro-drug thereof, | 03-31-2011 |
| 20110009386 | FURO[3, 2-B] PYRR0L-3-0NES AS CATHESPIN S INHIBITORS - A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt, hydrate, complex or pro-drug thereof, | 01-13-2011 |
| 20110009385 | COMPOUNDS - A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt, hydrate, complex or pro-drug thereof, | 01-13-2011 |
| 20100216811 | FURO[3. 2-B] PYRROL DERIVATIVES - The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein: R | 08-26-2010 |
| 20090203714 | Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors - The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, | 08-13-2009 |
| 20090192322 | Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates - The present invention relates to a process for preparing a compound of formula (Ia), (Ib), (Ic) or (Id), or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof, said process comprising the steps of: (A) (i) treating a compound of formula (IVa), where R | 07-30-2009 |
| 20090186831 | Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases - A compound of formula (I), or a pharmaceutically acceptable salt, hydrate, complex or pro-drug thereof, | 07-23-2009 |
